Entries by lizzi

New Dedicated Parathyroid Website

DeKalb Surgical Associates is pleased to announce the launching of ParathyroidAtlanta.com, a website dedicated to patient education regarding hyperparathyroidism. Hyperparathyroidism is a disease in which the calcium level in the blood is above the normal range, causing a variety of symptoms and potential complications. Years ago this was often a “silent disease”, only diagnosed after […]

Should I Get a 3D Mammogram?

Screening mammography of course has been recommended for women for many years. Typically it is recommended to begin at age 40, with annual mammograms thereafter. There are some institutions that have more recently recommended delaying screening mammograms until the age of 50, and then to consider doing them only every 2 years, unless the woman […]

John S. Kennedy, M.D. Named a Distinguished Cancer Scholar by the Georgia Cancer Coalition (GCC)

John S. Kennedy, M.D. has been named a Distinguished Cancer Scholar by the Georgia Cancer Coalition (GCC). The award recognizes Dr. Kennedy’s quest for cutting-edge cancer treatment and commitment to patients diagnosed with breast, colon and other cancers. A physician at DeKalb Medical for the past 22 years, Dr. Kennedy holds patents for medical instruments […]

Partial Breast Irradiation Method for Breast Cancer

Partial breast irradiation method for breast cancer shortens treatment time to five days. The treatment of breast cancer has become increasingly less invasive over the past several decades. More women than ever are opting for breast conservation therapy rather than a more invasive mastectomy. Still, breast conservation requires the use of radiation therapy after surgery. […]

DeKalb Surgical Associates in Atlanta Business Chronicle

Dekalb Surgeons Turn to Less Invasive Treatment Atlanta Business Chronicle – July 21, 2006 by Deborah Held Maslia, Contributing Writer According to the American Cancer Society, almost 213,000 women are expected to be diagnosed with invasive breast cancer in 2006, with 63.7 percent diagnosed when the tumor is still localized, or in its early stages. […]